These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacogenomics in cancer therapy: is host genome variability important? Petros WP; Evans WE Trends Pharmacol Sci; 2004 Sep; 25(9):457-64. PubMed ID: 15559247 [TBL] [Abstract][Full Text] [Related]
5. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?]. Lehne G; Bjørheim J; Saeter G Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies. Calvo E; Walko C; Dees EC; Valenzuela B Am Soc Clin Oncol Educ Book; 2016; 35():e175-84. PubMed ID: 27249721 [TBL] [Abstract][Full Text] [Related]
7. Cancer pharmacogenomics: achievements in basic research. Nakajima M; Yokoi T Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics in oncology]. Morán González D; Jiménez Cabrera S; Domínguez-Gil Hurlé A Med Clin (Barc); 2008 Jul; 131(5):184-95. PubMed ID: 18674490 [TBL] [Abstract][Full Text] [Related]
9. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes. van Schaik RH Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics for individualized cancer chemotherapy. Efferth T; Volm M Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel. Andriguetti NB; Raymundo S; Antunes MV; Perassolo MS; Verza SG; Suyenaga ES; Linden R Curr Med Chem; 2017; 24(33):3559-3582. PubMed ID: 28641556 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in cancer treatment. Nagasubramanian R; Innocenti F; Ratain MJ Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681 [TBL] [Abstract][Full Text] [Related]
13. Cancer pharmacogenomics: international trends. Yamayoshi Y; Iida E; Tanigawara Y Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of sex difference in chemotherapeutic toxicity. Wang J; Huang Y Curr Drug Discov Technol; 2007 Jun; 4(1):59-68. PubMed ID: 17630929 [TBL] [Abstract][Full Text] [Related]
15. Personalizing chemotherapy dosing using pharmacological methods. Patel JN; Papachristos A Cancer Chemother Pharmacol; 2015 Nov; 76(5):879-96. PubMed ID: 26298089 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of Drugs Used in the Treatment of Cancers. Franczyk B; Rysz J; Gluba-Brzózka A Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205356 [TBL] [Abstract][Full Text] [Related]
17. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics. Deeken JF; Figg WD; Bates SE; Sparreboom A Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetics of anticancer drugs]. de Chaisemartin L; Loriot MA Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657 [TBL] [Abstract][Full Text] [Related]